SoYoung, a Beijing-based online marketplace for aesthetic medical treatments in China, raised $60m in Series D funding.
CMAB Biopharma Inc., a BioBAY Park, Suzhou, China-based full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic products, completed a US$38m series A financing.
AIpark, a Beijing, China-based startup company that utilizes fourth-generation parking technology to manage city-wide road-side and garage parking systems, completed an over RMB 100m Series A financing.
UrWork (Beijing) Venture Investment Co.,Ltd., a Beijing, China-based co-working space provider, completed a $45M Series C funding.
ThinkForce, a Shanghai, China-based startup company specializing in Artificial Intelligence (AI) semiconductor chips, raised RMB450m in Series A funding.
XPENG Motors, a Beijing, China-based electric car startup, completed three rounds of series A+ financing and scheduled to disclose series B round in early 2018.
Clover Biopharmaceuticals, a Chengdu, China-based biotechnology company focused on developing novel and transformative biologic therapies, completed a RMB 62.8m (approximately US$9.5m) Series A financing.
SenseTime, a Chinese artificial intelligence company focused on computer vision and deep learning technologies, raised US$410m series B1 B round of financing.
MicuRx Pharmaceuticals, Inc., an Hayward, CA- and Shangai-based biopharmaceutical company, China-based closed a ¥100m financing.
ALO7 (Formerly known as Saybot), a China-based English language learning product and services provider, receives $37.5 million in Series D financing round.
TuSimple, a San Diego, CA and Beijing, China-based autonomous trucking company, raised $55m in Series C funding.
Fullerton Healthcare Corporation Limited, a provider of corporate healthcare solutions across Asia Pacific, received a significant investment from Ping An Capital Co., Ltd., the core equity investment platform of Ping An Insurance (Group) Company of China, Ltd.
EOC Pharma Group, a Shangai, China-based oncology-focused development and commercialization company, completed a $32m Series B financing.
Putiandi, a Shanghai, China-based one-stop platform for short-term site rental services, raised 90m yuan (approx. US$13.6m) in Series A financing.
Annoroad, a Beijing, China-based provider of genomics solutions, raised nearly $105m in Series C funding.